Assembly Biosciences, Inc. (ASMB) vs Tectonic Therapeutic, Inc. (TECX)

A side-by-side comparison of Assembly Biosciences, Inc. and Tectonic Therapeutic, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — ASMB vs TECX

growth of $100 · dividends reinvested · last 8y
ASMB -96.0% (-33.2%/yr)TECX -93.8% (-29.4%/yr)TECX compounded faster over this window
050100150Start $1002020202220242026$4$6
ASMB TECX

ASMB vs TECX: by the numbers

  • •ASMB is the larger company ($440M vs $423M market cap).

Metrics side by side

Valuation

MetricASMBTECX
P/E ratio40.33N/A
P/S ratio5.87N/A
P/B ratio1.441.89

Profitability

MetricASMBTECX
Gross margin99.82%0.00%
Operating margin-11.75%0.00%
Net margin-0.06%0.00%
ROE-0.01%-38.32%
ROIC-2.86%-41.88%

Growth (annualized)

MetricASMBTECX
Revenue CAGR (5Y)-1.78%N/A
Total return CAGR (5Y)-10.66%-18.45%

Frequently asked

How have ASMB and TECX total returns compared?
Over the past 5 years, ASMB delivered -10.66% and TECX delivered -18.45% annualized total return. Past performance doesn't predict future results.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.